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1013-7025/Copyright ª 2014, Hong Kong PhAbstract Background: Many stroke survivors continue to experience gait deficits. Functional
electrical stimulation may be a viable method to improve gait post-stroke.
Objective: The purpose of this parallel group controlled clinical trial was to investigate the
therapeutic effect of functional electrical stimulation (FES) on gait, motor recovery, and mo-
tor cortex activity.
Methods: Adults experiencing foot drop <6 months poststroke were allocated to the FES group
(physiotherapy and FES stimulation, n Z 14) or the control group (physiotherapy, n Z 14).
Each group received their respective therapy 5 days/week for 12 weeks. Gait, surface electro-
myography (sEMG) of the tibialis anterior muscle in the affected leg, and electroencephalo-
gram (EEG) signals from the foot motor area were assessed at baseline and again after the
12-week intervention.
Results: The results showed that the FES intervention induced significantly more changes in
various gait swing parameters such as foot pulling acceleration (measured in unit of gravita-
tional constant G; net between-group difference: 0.11  0.02 G, p Z 0.021), swing power
(0.11  0.03 G, p Z 0.027) and ground impact (0.12  0.04 G, p Z 0.046) than the control
group. EEG analysis revealed that the FES group had significantly altered beta-3 mean
(0.50  0.09, p Z 0.021), beta-4 mean (0.60  0.05, p Z 0.024) and alpha peak frequency
(0.15  0.02, pZ 0.035). Finally, analysis of sEMG data showed a significantly greater increase
in amplitude (in root mean square; 13.2  2.11 mV, p Z 0.033), mean power frequency
(5.5  0.80 Hz, p Z 0.024) and median power frequency (6.5  0.90 Hz, p Z 0.021) of the
tibialis anterior muscle on the affected side in the FES group.dical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, 721302, India.
itkgp.ernet.in, mmaha2@gmail.com (M. Mahadevappa).
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11Conclusion: FES combined with physiotherapy induced better outcomes in the swing phase of
the gait cycle, activation of the affected ankle dorsiflexor muscles and cortical function when
compared with conventional physiotherapy alone.
Copyright ª 2014, Hong Kong Physiotherapy Association Ltd. Published by Elsevier (Singapore)
Pte Ltd. All rights reserved.Introduction
Foot drop often results from the inability to dorsiflex the
foot during the swing phase of the gait cycle, and may be
observed in neurological conditions such as stroke. Func-
tional electrical stimulation (FES) has been used clinically
for correcting foot drop. It involves the application of a
sequence of stimulus pulses to the peroneal nerve of the
affected limb in patients with stroke. In 2009, National
Health Science (NHS)-UK issued an interventional procedure
guidance (National Institute for Health and Clinical Excel-
lence guideline Number IPG278) on the use of FES. NHS-UK
recommended the use of FES to address foot drop problems
of neurological origins [1].
An extensive review of the literature on FES clinical trials
revealed that the majority of research groups used walking
speed as the outcome measure to evaluate the efficacy of
FES [2]. Additional outcomes used were the Modified Ash-
worth Scale, FugleMeyer Assessment score, and range of
motion [3,4]. Presumably, if the use of the peroneal nerve
stimulator has a therapeutic effect on functional perfor-
mance, physiological changes should also be observed. Yet,
research on investigating the physiological changes and the
associated functional changes is scarce [5]. Further clinical
trials are thus necessary to investigate the physiological
changes occurring in the motor cortex, muscle function, and
improvement in gait. We advocate evaluating not only the
gait cycle, but also the surface electromyograms (sEMGs) of
stimulated muscles and the electroencephalogram (EEG)
signals from the stroke survivor’s motor cortex, to obtain a
more complete picture of post-FES changes. Conventional
gait parameters such as walking speed, cadence, and step
length do not adequately explain effects of FES. When
analysing hemiplegic gait, the swing phase dynamics are
more important than stance phase parameters [6], but so
far are unexplored by researchers [7]. In this study, we used
novel parameters that could be beneficial in exploring is-
sues such as quality of walking and foot clearance while
walking.
Post-FES sEMG changes should be analysed by looking at
their association with gait changes. FES is supposed to in-
crease muscle performance and consequently improve the
walking in people with hemiplegia. In addition to per-
forming an extended gait analysis for assessing functional
changes, we performed sEMG analysis to allow a better
understanding of how FES therapy affects muscle condition.
The available literature revealed that most of the EEG-
related work on persons with stroke had focused on analysis
of short duration EEG signals for identifying the motor-
related cortical potential or event-related desynchronisa-
tion [8e10]. The aim of these studies, however, was to
analyse EEG for use in brain-computer interface applica-
tions, rather than evaluating the therapeutic effects of FES.Until 2006, themajority of clinical trials on FES efficacy used
gait or changes in muscle function to evaluate post-FES
improvement. A frequently cited hypothesis by Rushton
[11] provided a new outlook on how FES improved motor
function. He highlighted that FES not only restored func-
tional abilities, but may also affect neural remodelling or
brain plasticity. Following this new outlook, researchers
began new experiments to explore how FES improved gait by
analysing EEG signals and movement-related cortical po-
tentials. One important weakness of many FES-induced EEG
modulation studies is that only a single session (30 minutes)
of FES was used and healthy individuals were evaluated
rather than clinically relevant populations [8e10]. To eval-
uate FES efficacy, a longer treatment may be required as
well. This study was also designed to evaluate the effects of
FES on the motor cortex by analysing EEGs obtained after 3
months of FES application.
Methods
Participant enrolment and trial registration
Individuals with the following criteria were included in the
study: history of stroke with hemiparesis at least 3 months
prior, medically stable, able to walk at least 10 metres
independently, having no established contraindication for
electric stimulation, and ability to give informed consent.
Exclusion criteria were: motor neuron injury affecting the
lower limbs with poor response to stimulation, history of
frequent fall (>1/week), severe cardiac disease such as
myocardial infarction, congestive heart failure, use of de-
mand pacemaker, fixed ankle contraction of 5 in plantar
flexion direction, or inability to operate the safety button of
the device on their own, if required. Please refer to our
detailed protocol of the registered trial available at www.
ctri.gov.in bearing the registration number CTRI/2012/09/
003019 for details. Our trial details are also available at the
World Health Organization International Clinical Trials Reg-
istry Platform. The study was approved by the ethical com-
mittees of the Indian Institute of Technology, Kharagpur,
India and the National Institute for the Orthopaedically
Handicapped, Kolkata, India.Written, informed consent was
obtained from the participants before actual data collection
and interventions took place. All procedures were con-
ducted in accordance with the Declaration of Helsinki.
Group assignment
A randomized controlled study design is considered the best
design for establishing cause and effect [12]. However, such
design has several limitations, including substantial financial
costs, intensive use of resources, compromised
12 C.V. Shendkar et al.generalisability of research findings, and the necessity for
external monitoring [13,14]. A controlled clinical trial study
design was used instead of the randomized controlled design
after consideration of practical feasibility and available
resources. Participants were assigned sequentially to the
FES or control group (Fig. 1). Stroke patients were assigned
to groups on a first-in, first-out basis.
The study involved 28 stroke patients equally divided into
two equal groups e FES and control. There were no statisti-
cally significant differences in the characteristics between
the two groups of patients at baseline. The details of enrol-
ment are shown in Fig. 1 and the characteristics of individuals
in the FES and control groups are shown in Table 1.
Intervention
The first arm (FES group) underwent FES therapy for 30 mi-
nutes and 30 minutes of conventional physiotherapy. A singleFigure 1. Flow diagram of the study. FEchannel stimulator (CEFAR Step II of Cefar Compex, now part
of DGO global, Vista, California, USA) was used to apply the
FES (Fig. 2A). The placement of the stimulator unit, elec-
trodes, and foot switch is shown in Fig. 2A. Patients walked
with the stimulator turned on for 30 minutes daily. Biphasic
charge balanced stimulation waveformwas used for applying
the stimulation. FES was delivered with 0.18-millisecond
pulses at 40 Hz; stimulation intensity level was adjusted be-
tween 20 mA and 50 mA to cause dorsiflexion in the affected
foot. FES was provided by electrotherapists, with analysis
performed by the authors. Physiotherapy was provided by
physiotherapists recognized by the government of India.
Conventional physiotherapy was provided for the second
arm (control) as it would have been unethical to withdraw
all treatment. Patients in the control group underwent
exercise with a trained physiotherapist for 60 minutes,
involving stretching, a range of motion enhancement exer-
cises, muscle strengthening, and gait and balance training.S Z functional electrical stimulation.
Table 1 Characteristics of participants
Parameter FES group Control group p (between group
comparisons for
those who completed
follow-up assessment)
All recruited
participants
(n Z 17)
Participants who
completed follow-up
assessment (n Z 14)
All recruited
participants
(n Z 17)
Participants who
completed follow-up
assessment (n Z 14)
Male/female, n 11/6 9/5 11/6 9/5 0.993
Age (y) 50.2  9.3 51.0  11.0 49.8  10.7 48.7  12.7 0.454
Body weight (kg) 59.3  7.3 60.4  8.0 62.7  9.5 62.2  12.7 0.665
Body height (cm) 164.4  5.8 164.2  6.0 165.6  4.7 165.2  4.0 0.569
Left/right side affected, n 6/11 5/9 5/12 4/10 0.877
Time since stroke (mo) 5.2  0.9 5.5  0.7 5.3  0.7 5.2  0.8 0.825
Stroke type
(ischaemic/haemorrhagic), n
15/2 12/2 15/2 12/2 0.992
Data are presented as mean  standard deviation, unless otherwise indicated.
FES Z functional electrical stimulation.
13Interventions for both groups were applied 5 days/week, for
up to 12 weeks.
Measurements
Gait, EEG, and sEMG measurements were performed at two
time points: baseline and after 12 weeks of FES interven-
tion. Gait, EEG, and sEMG signals were obtained sequen-
tially. The definitions of various outcome variables derived
from these measurements are shown in Appendix 1. The
persons who performed the outcome measurements were
blinded to group allocation.
A wireless portable gait analyser (MiniSun LLC, Fresno,
CA, USA) was used to acquire gait data. Fig. 2B shows the
gait acquisition device with placement of sensors. The pa-
tients were asked to walk along a hospital passage over a 50
metre course. All patients walked this course without
stimulation. Parameters including walking speed, cadence,
step length, single limb support (SLS), double limb support
(DLS), pulling power, swing power, and ground impact were
acquired using the portable gait analyser. The details are
given in Table 2.Figure 2. Protocol for functional electrical stimulation (FES) de
tromyography (sEMG) and electroencephalogram (EEG) signals. (A)
wireless portable gait analyser; (C) EEG acquisition from Cz point a
sEMG recording from tibialis anterior (TA) muscles of affected limbEEG signals were also measured. The feasibility of using
one or two EEG channels (by placing the electrodes on Fz,
Cz locations as per 10e20 electrode placement system) for
acquisition and analysis of foot movement-related changes
in the motor cortex area has been well established in stroke
rehabilitation in the past decade [8e10]. We used the
guidelines of the International Federation of Clinical
Neurophysiology (IFCN) for digital recording of the EEG data
[13]. We used a single EEG electrode on the Cz location,
which is in proximity to the foot motor area. Placement of
an electrode on the Cz location was performed as shown in
Fig. 2C. Somatotopic mapping of the human primary
sensorimotor cortex during foot motor imagery and motor
execution shows that a large part of the motor cortex is
associated with foot movement [15]. This area is repre-
sented as the Cz point in the 10e20 EEG electrode place-
ment system. The chances of incorrect Cz electrode
placement was small, due to the comparatively large size
of the motor area. Standard processes were applied while
positioning the electrode to avoid variability and
misplacement of electrodes. The EEG signal was recorded
with a linked ear reference from the Cz location of thelivery and method used for acquisition of GAIT, surface elec-
Method used for application of FES; (B) gait measurement using
ccording to standard 10e20 International EEG system; and (D)
.
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14 C.V. Shendkar et al.scalp. To ensure reproducibility of the signal, EEG signal
electrodes were placed close to the foot motor area, which
was represented by the Cz point according to the interna-
tional 10e20 system. EEG data were recorded using an
acquisition device (Biograph Infiniti, Thought Technology,
Montreal, QC, Canada). Participants were asked to sit
comfortably on a chair with the knee flexed at 90 and the
ankle in a neutral position as shown in Fig. 2C. Data were
recorded for a total period of 5 minutes while performing
dorsiflexion of the ankle of the affected limb at intervals of
5 seconds. A sampling frequency of 256 Hz was used for
data acquisition. Data were later processed using Matlab
(Math Works Inc., Natick, MA, USA).
European recommendations (the Surface Electromyog-
raphy for the Non-Invasive Assessment of Muscles or SENIAM
project) and the International Society of Electrophysiology
and Kinesiology (ISEK) standards for acquisition and pro-
cessing of sEMG data were followed [16]. Electrode position,
sampling frequency, and filter parameters were set ac-
cording to these international standards. Data acquisition
was performed using a bio-potential data acquisition system
(PowerLab, AD Instruments, Bella Vista, NSW, Australia).
sEMG of the tibialis anterior muscle of the affected limb was
recorded during voluntary contraction. The FES device was
turned off while the sEMG signal was recorded. Electrode
placement and the sEMG acquisition process are shown in
Fig. 2D.
Isometric maximum voluntary contraction was used as
an sEMG normalization strategy [17]. The participants were
asked to sit on a chair with the knee flexed at 90 and the
ankle in a neutral position. Each performed active ankle
dorsiflexion of the affected lower limb at a uniform
contraction rate and force approximately 15 times during
the 150 seconds of data recording.Data processing
The gait, sEMG, and EEG signals were acquired at pre- and
post-intervention for each individual. Typical gait, sEMG,
and EEG signals obtained are displayed in Fig. 3A, B, and
C, respectively. The gait cycle measured by the sensor
from both hemiplegic and contralateral lower limbs, EEG
signal acquired from motor cortex by positioning elec-
trodes at the Cz location according to standard 10e20
electrode placement system, and sEMG signal acquired
from tibialis anterior muscle of the affected limb are
shown.
EEG signals were processed and separated into delta,
theta, alpha, SMR, beta, beta-1, -2, -3, gamma, and wide
band. IFCN guidelines were used to select filter type, filter
order, ripple setting, cut-off frequencies, and dampening
settings [14]. Information about the time and frequency
domain was extracted from all the bands for analysis.
Analysis was performed using MATLAB R2010b (Mathwork
Inc. Natick, MA, USA) and the statistical analysis software
SPSS Inc. (version 17.0, Chicago, IL, USA). SENIAM, ISEK
standards, and general good practice guidelines were fol-
lowed to remove artefacts while processing the sEMG data.
All data were sampled at 1000 Hz with a 12-bit A/D con-
verter. Low-pass filtering (4th-order Bessel filter,  3% ac-
curacy, frequencies 500 Hz at 3 dB), high-pass filtering
Figure 3. Gait, surface electromyography (sEMG) and electroencephalogram (EEG) signals. (A) Shows gait cycle measured by the
sensor from both, hemiplegic and counter lower limbs; (B) EEG signal acquired from the motor cortex by positioning electrode at Cz
location according to standard 10e20 electrode placement system; and (C) sEMG signal acquired from the tibialis anterior muscle
of the affected limb.
15(1st-order filter,  0.25% accuracy, frequencies 20 Hz at
3 dB), and notch filtering (2nd-order filter, frequencies
50 Hz at 32 dB) were used for data processing. We fol-
lowed the standards for reporting sEMG data [15]. Segments
of sEMG during dorsiflexion of the lower limb were used for
analysis. Both temporal and spectral parameter analyses
were performed.
Statistical analysis
Statistical analyses were performed with SPSS 17.0 (SPSS
Inc.). First, differences in the characteristics of the par-
ticipants between the FES group and the control group werecompared using the independent t test (for interval or ratio
data), the Mann-Whitney U test (for ordinal data), and the
Chi-square test (for nominal data). The Kolmogorov-
Smirnov test was used to check the normality of data. As
aforementioned, no statistically significant differences in
the characteristics between the two groups of patients
were observed (Table 1).
To investigate the therapeutic effects of FES on the
outcome measures, two-way analysis of variance (ANOVA)
with repeated measures was used. In each of the ANOVA
models, a mixed design was used, with time as the within-
participant factor (baseline measurement vs. post-
intervention measurement) and group as the between-
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16 C.V. Shendkar et al.participant factor (FES vs. control). For those variables that
showed significant group  time interaction in the ANOVA,
independent t tests were used to compare the change score
between the two groups. In addition, paired t tests were
used to examine changes over time in each group. A p value
<0.05 was considered statistically significant in change
score and group  time interaction analysis. The signifi-
cance level was adjusted to 0.025 for the post hoc com-
parison of the pre- and post-test scores for each group.
Results
Gait analysis
In order to gain a comprehensive overview of the influence
of FES on gait, both conventional parameters, such as
walking speed, cadence, step length, SLS, and DLS, and
new parameters, such as pulling power, swing power, and
ground impact, were used [18,19].
Among the gait variables (Table 2), the pulling acceler-
ation (F Z 8.911, p Z 0.009), swing power (F Z 6.020,
p Z 0.024), and ground impact (F Z 4.793, p Z 0.049)
demonstrated significant group  time interactions. In the
FES group, pulling acceleration (initial swing) improved by
13.8% (p Z 0.008), swing power (terminal swing) by 14.2%
(pZ 0.010), and ground impact by 18.6% (pZ 0.020; Table
2). In the control group, the pulling power improved by only
8.3% (p Z 0.015), swing power by 7.8% (p Z 0.020), and
ground impact by 5.6% (p Z 0.020). The change score re-
sults showed that the FES intervention induced significantly
more changes in various gait swing parameters such as
foot pulling acceleration (mean between-group
difference Z 0.11  0.02, p Z 0.021), swing power
(0.11  0.03, p Z 0.027), and ground impact (0.12  0.04,
p Z 0.046) than the control group. Other gait variables
demonstrated no significant group  time interaction ef-
fects (p > 0.05), indicating that FES had no therapeutic
effects on these outcomes compared with the control
treatment.
EEG analysis
There was a significant group  time interaction effect for
beta-3 mean (F Z 7.139, p Z 0.018), beta-4 mean
(F Z 6.575, p Z 0.022), and alpha peak frequency
(F Z 6.466, p Z 0.025) (Table 3).
Analysis of the change scores revealed that the FES group
had significantly more changes in beta-3 mean (mean
between-group differenceZ 0.50 0.09, pZ 0.021), beta-
4 mean (0.60  0.05, pZ 0.024) and alpha peak frequency
(0.15  0.02, pZ 0.035) compared with the controls.
sEMG analysis
Significant group  time interaction effects were detected
for Root mean square (RMS; also known as quadtratic mean)
value (F Z 6.575, p Z 0.028), mean power frequency
(F Z 8.802, p Z 0.010), and median power frequency
(F Z 6.910, p Z 0.014) (Table 4). Post hoc analysis of the
change scores showed that the FES group had significantly
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17more improvements in root mean square value (mean
between-group difference Z 13.2  2.11, p Z 0.033),
mean power frequency (5.5  0.80, pZ 0.024), and median
power frequency (6.5  0.90, p Z 0.021) of the tibialis
anterior muscle on the affected side compared with the
controls. No other significant results were observed in other
sEMG parameters.
Temporal parameter improvement showed the
enhancement of muscle force produced by the tibialis
anterior muscle [20,21]. Analysis of spectral parameters of
sEMG signals showed a significant shift in spectral values
post-FES, and shifts in the mean and median power fre-
quencies towards the higher frequencies. Spectral edge
frequencies also shifted towards higher values post-FES.
These variations in sEMG spectral frequency post-FES
therapy indicated a concomitant increase in muscle fibre
conduction velocity [22].T
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).Discussion
This work showed the functional and physiological changes
that occurred following 3 months of FES therapy. This study
is unique for two main reasons. First, extensive gait analysis
was performed to improve our understanding of post-FES
stance and swing phase dynamics and second, the muscular
(motor recovery pattern) and cortical changes were eval-
uated in addition to the gait outcomes.
The gait assessment used in this study was different
from existing studies in two main ways. First, instead of
using a conventional walking test such as the 6 minute
walking test, figure-of-8 walking test, or the 10 metre
walkway, we conducted a longer-distance walking test (50
metres). This improved gait data acquisition and minimized
the effect of individual walking style, which can be present
when shorter distances are examined. We analysed pa-
rameters including pulling power, swing power, ground
impact, and ratio of SLS to DLS (SLS/DLS) [23,24], to pro-
vide both stance phase and swing phase dynamics.
The results showed that the FES therapy had significant
treatment effects on pulling power, swing power, and
ground impact, as revealed by the significant group  time
interaction. These changes reflect an improvement in ankle
dorsiflexion ability and thus foot clearance.
It is important to determine whether the gait changes
are accompanied by changes in the neural system. How-
ever, the literature concerning cortical changes associated
with long-term use of FES is limited [8,25]. Studies evalu-
ating EEGs of healthy individuals have already established
that limb movement (flexion) modulates the cortical po-
tential. Nascimento and co-workers [26] concluded that
information concerning movement-related parameters for
plantar-flexion tasks are encoded in the primary motor
cortex (M1), and a separate group of researchers found that
beta oscillations induced by movement or stimulation of
the lower limb were best recorded over the corresponding
cortical representation area (Cz) [27]. We therefore
focused on finding the FES-related changes in the motor
cortex.
Human EEG studies have shown that changes in the
alpha (8e13 Hz) and beta (15e25 Hz) bands can be used to
detect functional activation of sensorimotor cortex.
18 C.V. Shendkar et al.Research carried out by Fabrizio De Vico Fallani and co-
workers, or you could keep this as De Vico Fallani and co-
workers [28] showed how stroke significantly changed the
structural properties of the brain networks associated with
preparation and execution of motor movements, and
concluded that poststroke changes were particularly
prominent in the beta band (13e29 Hz), known to be
involved in motor tasks. Giaquinto and co-workers [29]
(1994) attempted to quantify values of EEG following
stroke and their possible correlation with stroke recovery,
and found that alpha mean frequency was reduced in the
injured hemisphere following stroke. These findings thus
suggested that alterations in beta band and alpha fre-
quency may be indicative of functional improvement
following neurostimulation or physiotherapy.
In this study, EEG was used as an outcome measure to
evaluate the effects of FES on the motor cortex. EEG
temporal parameters (alpha, beta, gamma, delta, theta,
sensorimotor rhythm-mu, and wide band) and spectral pa-
rameters (alpha peak frequency) were analysed to deter-
mine the possible effects of FES on the motor cortex. Our
analysis showed that our FES protocol had significant ef-
fects on beta-3 and -4 band amplitudes and alpha peak
modulation, suggesting that FES induced changes in the
sensory-motor cortex area (e.g., strengthened cortico-
spinal connections) in persons with foot drop [30]. Similar
results were observed by Neuper and Pfurtscheller [27] in
healthy individuals. They found that different cortical
processes, such as recovery from movement and stimula-
tion, resulted in beta oscillations in the frequency range of
14e35 Hz in healthy individuals [27]. We performed tibialis
anterior muscle sEMG analysis in both temporal and spec-
tral domains and evaluated the significance of improve-
ment in muscle condition. In the kinesiology research
community, using only spectral analysis for understanding
muscle conditions after therapy is controversial [31]. We
therefore focused our work on investigating motor changes
by including both the temporal and spectral features of a
post-FES signal. These changes were associated with mus-
cle fibre conduction velocity.
The FES program induced significant improvements in EMG
amplitude (in RMS value), mean frequency, and medianAppendix 1. Definitions of analysed gait, electro
electromyography (sEMG) parameters
GAIT parameters Single limb support (ms) Single-limb su
which the bod
Double limb support (ms) Double-limb s
which both fe
SLS/DLS (%) It is the ratio
support durat
Pulling acceleration
(initial swing) (G)
The pulling ac
forward accel
Swing power
(terminal swing) (G)
The swing pow
the mid and t
Ground impact (G) Ground impac
vertical direcfrequency compared with the control group (Table 4). These
changes are indicative of improved motor strength and mus-
cle fibre conduction velocity following FES therapy [32].
Limitations
A major limitation of this study was the lack of random
allocation of individuals to the two treatment groups.
However, no significant differences in important charac-
teristics were identified between the two groups.
Conclusion
Our study showed that 3 months of FES intervention
induced significant therapeutic effects in hemiplegic pa-
tients with foot drop. Comprehensive gait analysis revealed
that FES improved quality of walking and foot clearance.
These improvements are accompanied by changes in ankle
muscle activation and cortical activity.
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(continued )
Speed (m/min) Speed is computed using the actual stride length/actual stride time
Cadence (steps/min) Cadence is the rate at which a person walks
Step length (m) Step length is the distance between the proximal end position
of the foot at ipsilateral heel strike to the proximal end position
of the foot at the next contralateral heel strike
Stride length (m) Stride length is the distance between proximal end position of the
foot at ipsilateral heel strike to the proximal end position of the
foot at the next ipsilateral heel strike
EEG parameters Wide band amplitude (mV) It is periodic averages of EEG signal epoch for 1e38 Hz frequency band
Beta-3 mean (mV) It is periodic averages of EEG signal epoch for 22e26 Hz frequency band
Beta-4 mean (mV) It is periodic averages of EEG signal epoch for 26e30 Hz frequency band
Beta-5 mean (mV) It is periodic averages of EEG signal epoch for 30e38 Hz frequency band
Alpha peak frequency (Hz) From the raw EEG, a fast Fourier transform calculation (FFT) is calculated
and the frequency value of the highest frequency in the alpha range
(8e12 Hz) of the spectrum is measured as alpha peak frequency
sEMG parameters sEMG RMS value (mV) sEMG RMS value obtained by computing the root mean square value in a
particular time window (here dorsiflexion duration) of the raw EMG
sEMG peak value (mV) It is a value where sEMG amplitude reaches to its peak in particular time
window (here dorsiflexion duration)
Average slope (mV/s) It is a time domain feature that measures the relative average slope of
the EMG signal
Mean power frequency (Hz) Mean power frequency is a frequency at which the average power within
the signal is reached
Median power frequency (Hz) Median power frequency is a frequency at which the total power within
the signal reaches 50% of its maximum value
Spectral edge frequency (Hz) Spectral edge frequency indicates the highest frequency below which
95% of the total power is located
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